5-Bromo-2'-deoxyuridine (59-14-3)


Study Results


Genetic Toxicology

Rodent Cytogenetics
CA SCE
    • Negative (Nonstandard Protocol)
    • Positive
    • Negative
    • Negative
    • Negative
    • Negative
    • Positive
    • Negative
    • Negative
    • Negative
    • Equivocal
    • Positive
    • Negative
    • Negative
    • Positive
    • Negative
    • Positive
    • Negative
    • Positive (Nonstandard Protocol)
    • Not a Valid Test
    • Negative
    • Negative
    • Negative
    • Negative (Nonstandard Protocol)
    • Negative
    • Negative
    • Negative
    • Negative (Nonstandard Protocol)
    • Negative
    • Negative (Nonstandard Protocol)
    • Positive
    • Equivocal
    • Positive (Nonstandard Protocol)
    • Positive
    • Negative
    • Positive (Nonstandard Protocol)
    • Negative
    • Negative
    • Negative
    • Positive (Nonstandard Protocol)
    • Negative
    • Negative
    • Negative
    • Negative
    • Negative
    • Positive
    • Positive (Nonstandard Protocol)
    • Negative (Nonstandard Protocol)
    • Positive
    • Negative (Nonstandard Protocol)
    • Negative
    • Positive
    • Negative (Nonstandard Protocol)
    • Positive
    • Negative
    • Positive
    • Negative (Nonstandard Protocol)
    • Positive
    • Negative
    • Negative
    • Negative
    • Negative
    • Negative (Nonstandard Protocol)
    • Positive
    • Negative
    • Negative (Nonstandard Protocol)
    • Positive (Nonstandard Protocol)
    • Negative
    • Negative (Nonstandard Protocol)
    • Negative
    • Positive
    • Negative
    • Negative
    • Positive (Nonstandard Protocol)
    • Positive (Nonstandard Protocol)
    • Negative
    • Negative
    • Negative (Nonstandard Protocol)
    • Negative
    • Negative
    • Negative
    • Positive (Nonstandard Protocol)
    • Positive
    • Negative
    • Positive
    • Negative
    • Positive
    • Equivocal
    • Positive
    • Negative
    • Negative
    • Positive (Nonstandard Protocol)
    • Positive (Nonstandard Protocol)
    • Positive
    • Equivocal
    • Negative
    • Negative
    • Negative
    • Negative (Nonstandard Protocol)
    • Positive
    • Negative (Nonstandard Protocol)
    • Negative
    • Negative
    • Negative (Nonstandard Protocol)
    • Negative (Nonstandard Protocol)
    • Positive
    • Negative
    • Negative (Nonstandard Protocol)
    • Negative
    • Positive
    • Positive (Nonstandard Protocol)
    • Negative (Nonstandard Protocol)
    • Positive
    • Negative
    • Negative
    • Positive
    • Negative (Nonstandard Protocol)
    • Negative
    • Positive
    • Negative
    • Negative (Nonstandard Protocol)
    • Negative
    • Positive (Nonstandard Protocol)
    • Positive (Nonstandard Protocol)
    • Equivocal
    • Positive
    • Negative
    • Positive
    • Negative
    • Negative (Nonstandard Protocol)
    • Negative (Nonstandard Protocol)
    • Positive (Nonstandard Protocol)
    • Positive (Nonstandard Protocol)
    • Negative
    • Negative
    • Positive
    • Positive
    • Positive
    • Positive (Nonstandard Protocol)
    • Equivocal
    • Positive
    • Negative (Nonstandard Protocol)
    • Positive
    • Negative (Nonstandard Protocol)
    • Positive
    • Positive
    • Positive
    • Equivocal
    • Positive (Nonstandard Protocol)
    • Positive
    • Positive
    • Negative (Nonstandard Protocol)
    • Negative
    • Positive
    • Positive
    • Positive (Nonstandard Protocol)
    • Negative
    • Negative
    • Negative (Nonstandard Protocol)
    • Positive
    • Negative (Nonstandard Protocol)
    • Positive
    • Negative
    • Negative (Nonstandard Protocol)
    • Negative
    • Positive
    • Positive
    • Negative
    • Negative (Nonstandard Protocol)
    • Negative (Nonstandard Protocol)
    • Positive
    • Positive
    • Negative
    • Positive
    • Negative
    • Positive (Nonstandard Protocol)
    • Positive
    • Positive
    • Negative (Nonstandard Protocol)
    • Positive
    • Negative (Nonstandard Protocol)
    • Negative
    • Negative (Nonstandard Protocol)
    • Negative
    • Negative (Nonstandard Protocol)
    • Negative
    • Positive
    • Negative
    • Positive (Nonstandard Protocol)
    • Negative
    • Equivocal
    • Positive (Nonstandard Protocol)
    • Negative (Nonstandard Protocol)
    • Positive (Nonstandard Protocol)
    • Negative (Nonstandard Protocol)
    • Positive
    • Negative
    • Not a Valid Test
    • Negative
    • Positive
    • Negative
    • Negative
    • Negative
    • Negative (Nonstandard Protocol)
    • Positive
    • Positive (Nonstandard Protocol)
    • Negative (Nonstandard Protocol)
    • Negative (Nonstandard Protocol)
    • Negative (Nonstandard Protocol)
    • Equivocal
    • Positive
    • Positive (Nonstandard Protocol)
    • Negative (Nonstandard Protocol)
    • Negative (Nonstandard Protocol)
    • Positive
    • Negative (Nonstandard Protocol)
    • Negative (Nonstandard Protocol)
    • Negative (Nonstandard Protocol)
    • Positive
    • Positive
    • Negative
    • Positive (Nonstandard Protocol)
    • Negative (Nonstandard Protocol)
    • Negative
    • Negative (Nonstandard Protocol)
    • Negative (Nonstandard Protocol)
    • Negative
    • Positive
    • Negative (Nonstandard Protocol)
    • Negative
    • Negative
    • Negative (Nonstandard Protocol)
    • Not a Valid Test
    • Positive (Nonstandard Protocol)
    • Positive
    • Negative (Nonstandard Protocol)
    • Positive
    • Positive (Nonstandard Protocol)
    • Positive
    • Negative (Nonstandard Protocol)
    • Negative (Nonstandard Protocol)
    • Negative (Nonstandard Protocol)

Citation Information


NTP. 5-Bromo-2'-deoxyuridine (59-14-3). Chemical Effects in Biological Systems (CEBS). Research Triangle Park, NC (USA): National Toxicology Program (NTP). Accessed 2017-10-23. https://manticore.niehs.nih.gov/cebssearch/test_article/59-14-3

Study Data


Genetic Toxicology